Found 385 chains in Genus chains table. Displaying 1 - 50. Applied filters: Proteins

Search results query: SHC Adaptor Protein

Total Genus Sequence Length pdb Title
11 114 1bljA Nmr ensemble of blk sh2 domain, 20 structures
14 107 1hctB Nmr structure of the human src sh2 domain complex
14 112 1fhsA The three-dimensional solution structure of the src homology domain-2 of the growth factor receptor bound protein-2, nmr, 18 structures
13 109 1ab2A Three-dimensional solution structure of the src homology 2 domain of c-abl
14 114 1blkA Nmr ensemble of blk sh2 domain using chemical shift refinement, 20 structures
11 106 1aouF Nmr structure of the fyn sh2 domain complexed with a phosphotyrosyl peptide, 22 structures
18 111 1bfiA Solution structure of the c-terminal sh2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase, nmr, 30 structures
11 112 1csyA Syk tyrosine kinase c-terminal sh2 domain complexed with a phosphopeptidefrom the gamma chain of the high affinity immunoglobin g receptor, nmr
17 95 1ghuA Nmr solution structure of growth factor receptor-bound protein 2 (grb2) sh2 domain, 24 structures
155 575 1bf5A Tyrosine phosphorylated stat-1/dna complex
181 581 1bg1A Transcription factor stat3b/dna complex
164 581 4e68A Unphosphorylated stat3b core protein binding to dsdna
24 101 3s8oA Crystal structure of the grb2 sh2 domain in complex with a pyxn-derived tripeptide
21 114 3s9kA Crystal structure of the itk sh2 domain.
23 101 3s8nA Crystal structure of the grb2 sh2 domain in complex with a pyxn-derived tripeptide
153 522 5ibmA Structure of s502p, a cancer-associated mutation of the oncogenic phosphatase shp2
158 523 5i6vA Structure of f285s, a cancer-associated mutation of the oncogenic phosphatase shp2
107 303 5hkyA Crystal structure of c-cbl tkbd domain in complex with spry2 peptide (36-60, py55) refined to 1.8a resolution (p6 form)
16 98 5cdwA Crystal structure analysis of a mutant grb2 sh2 domain (w121g) with a pyvnv peptide
40 168 5bo4A Structure of socs2:elongin c:elongin b from dmso-treated crystals
28 108 4f5bA Triple mutant src sh2 domain bound to phosphotyrosine
29 108 4f59A Triple mutant src sh2 domain
58 243 4fbnA Insights into structural integration of the plcgamma regulatory region and mechanism of autoinhibition and activation based on key roles of sh2 domains
28 108 4f5aA Triple mutant src sh2 domain bound to phosphate ion
54 243 4ey0A Structure of tandem sh2 domains from plcgamma1
24 101 4eihA Crystal structure of arg sh2 domain
107 377 4e93A Crystal structure of human feline sarcoma viral oncogene homologue (v-fes)in complex with tae684
154 526 4dgpA The wild-type src homology 2 (sh2)-domain containing protein tyrosine phosphatase-2 (shp2)
162 525 4dgxA Leopard syndrome-associated shp2/y279c mutant
32 163 4d8kA Crystal structure of a sh3-sh2 domains of a lymphocyte-specific protein tyrosine kinase (lck) from homo sapiens at 2.36 a resolution
123 388 4a4bA Structure of modified phosphotyr371-c-cbl-ubch5b-zap-70 complex
132 390 3zniA Structure of phosphotyr363-cbl-b - ubch5b-ub - zap-70 peptide complex
122 388 4a4cA Structure of phosphotyr371-c-cbl-ubch5b-zap-70 complex
24 96 3wa4A Grb2 sh2 domain/cd28-derived peptide complex
117 447 3vs6A Crystal structure of hck complexed with a pyrazolo-pyrimidine inhibitor tert-butyl {4-[4-amino-1-(propan-2-yl)-1h-pyrazolo[3,4-d]pyrimidin-3-yl]-2-methoxyphenyl}carbamate
116 447 3vs2A Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 7-[cis-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine
103 309 3vrpA Crystal structure of the tyrosine kinase binding domain of cbl-c in complex with phospho-egfr peptide
98 309 3vrnA Crystal structure of the tyrosine kinase binding domain of cbl-c
104 305 3vrrA Crystal structure of the tyrosine kinase binding domain of cbl-c (pl mutant) in complex with phospho-egfr peptide
122 447 3vryA Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 4-amino-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-7-yl-cyclopentane
100 308 3vroA Crystal structure of the tyrosine kinase binding domain of cbl-c in complex with phospho-src peptide
110 447 3vs4A Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 5-(4-phenoxyphenyl)-7-(tetrahydro-2h-pyran-4-yl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine
123 447 3vs3A Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine
106 447 3vs7A Crystal structure of hck complexed with a pyrazolo-pyrimidine inhibitor 1-cyclopentyl-3-(1h-pyrrolo[2,3-b]pyridin-5-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine
109 447 3vs0A Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor n-[4-(4-amino-7-cyclopentyl-7h-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]benzamide
112 447 3vs1A Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7h-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-phenylurea
117 447 3vrzA Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7h-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-benzylurea
95 310 3vrqA Crystal structure of the tyrosine kinase binding domain of cbl-c (pl mutant)
116 447 3vs5A Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor 7-(1-methylpiperidin-4-yl)-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine
21 97 3us4A Crystal structure of a sh2 domain of a megakaryocyte-associated tyrosine kinase (matk) from homo sapiens at 1.50 a resolution